ERBB Signaling Interrupted: Targeting Ligand-Induced Pathway Activation
Wilson FH, Politi K. ERBB Signaling Interrupted: Targeting Ligand-Induced Pathway Activation. Cancer Discovery 2018, 8: 676-678. PMID: 29858224, PMCID: PMC6330656, DOI: 10.1158/2159-8290.cd-18-0368.Commentaries, Editorials and LettersMeSH KeywordsAdenocarcinoma of LungCell Line, TumorHumansLigandsNeuregulin-1Receptor, ErbB-2Receptor, ErbB-3Signal Transduction